{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T17:41:11Z","timestamp":1791740471708,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004387","name":"Ningbo University","doi-asserted-by":"publisher","award":["421912073"],"award-info":[{"award-number":["421912073"]}],"id":[{"id":"10.13039\/501100004387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LY24C190001"],"award-info":[{"award-number":["LY24C190001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107945","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T01:53:15Z","timestamp":1730771595000},"page":"107945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Structure-Based identification of a potent KDM7A inhibitor exerts anticancer activity through transcriptionally reducing MKRN1 in taxol- resistant and -sensitive triple-negative breast cancer cells"],"prefix":"10.1016","volume":"153","author":[{"given":"Jin-Jin","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Guo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan\u2011Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2024.107945_b0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41392-023-01341-7","article-title":"Targeting epigenetic regulators to overcome drug resistance in cancers","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"10.1016\/j.bioorg.2024.107945_b0010","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.15252\/embr.201541113","article-title":"Histone demethylases in chromatin biology and beyond","volume":"16","author":"Dimitrova","year":"2015","journal-title":"EMBO Rep"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107945_b0015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrm3327","article-title":"Molecular mechanisms and potential functions of histone demethylases","volume":"13","author":"Kooistra","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107945_b0020","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41392-022-01145-1","article-title":"JMJD family proteins in cancer and inflammation","volume":"7","author":"Manni","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"10.1016\/j.bioorg.2024.107945_b0025","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrd4154","article-title":"Histone lysine demethylases as targets for anticancer therapy","volume":"12","author":"H\u00f8jfeldt","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1016\/j.bioorg.2024.107945_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23123194","article-title":"Pharmacological Inhibition of LSD1 for Cancer Treatment","volume":"23","author":"Yang","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107945_b0035","article-title":"A state-of-the-art review on LSD1 and its inhibitors in breast cancer: Molecular mechanisms and therapeutic significance","volume":"13","author":"Yang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bioorg.2024.107945_b0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/bs.apcsb.2019.08.005","article-title":"Structure-function relationships in KDM7 histone demethylases","volume":"117","author":"Chaturvedi","year":"2019","journal-title":"Adv Protein Chem Struct Biol"},{"key":"10.1016\/j.bioorg.2024.107945_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115799","article-title":"Lysine-specific demethylase 7A (KDM7A): A potential target for disease therapy","volume":"216","author":"Li","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"51","key":"10.1016\/j.bioorg.2024.107945_b0050","doi-asserted-by":"crossref","first-page":"20725","DOI":"10.1073\/pnas.1108462109","article-title":"Increased expression of histone demethylase JHDM1D under nutrient starvation suppresses tumor growth via down-regulating angiogenesis","volume":"108","author":"Osawa","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bioorg.2024.107945_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.993775","article-title":"Berberine as a potential agent for breast cancer therapy","volume":"12","author":"Zhong","year":"2022","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107945_b0060","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.apsb.2021.10.024","article-title":"Inhibition of the CDK9-cyclin T1 protein-protein interaction as a new approach against triple-negative breast cancer","volume":"12","author":"Cheng","year":"2022","journal-title":"Acta Pharm Sin B"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107945_b0065","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.gendis.2021.06.005","article-title":"Discovery of a tetrahydroisoquinoline-based CDK9-cyclin T1 protein-protein interaction inhibitor as an anti-proliferative and anti-migration agent against triple-negative breast cancer cells","volume":"9","author":"Cheng","year":"2022","journal-title":"Genes Dis"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107945_b0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12943-024-02011-0","article-title":"KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges","volume":"23","author":"Li","year":"2024","journal-title":"Mol Cancer"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107945_b0075","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/cai2.96","article-title":"Bioinformatics analysis of human kallikrein 5 (KLK5) expression in metaplastic triple-negative breast cancer","volume":"2","author":"Song","year":"2023","journal-title":"Cancer Innov"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107945_b0080","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1002\/cai2.124","article-title":"A lactate-responsive gene signature predicts the prognosis and immunotherapeutic response of patients with triple-negative breast cancer","volume":"3","author":"Feng","year":"2024","journal-title":"Cancer Innov"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107945_b0085","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41467-024-45160-y","article-title":"The anti-PD-L1\/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel in first-line treatment of metastatic triple-negative breast cancer: a multicenter phase II trial","volume":"15","author":"Li","year":"2024","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107945_b0090","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1002\/cai2.146","article-title":"Multiomics and single-cell sequencings reveal the specific biological characteristics of low Ki-67 triple-negative breast cancer","volume":"3","author":"Han","year":"2024","journal-title":"Cancer Innov"},{"key":"10.1016\/j.bioorg.2024.107945_b0095","article-title":"The Jumonji Domain-Containing Histone Demethylase Homolog 1D\/lysine Demethylase 7A (JHDM1D\/KDM7A) Is an Epigenetic Activator of RHOJ Transcription in Breast Cancer Cells","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107945_b0100","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/jcp.29008","article-title":"Histone demethylase KDM7A is required for stem cell maintenance and apoptosis inhibition in breast cancer","volume":"235","author":"Meng","year":"2020","journal-title":"J Cell Physiol"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107945_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010092","article-title":"Structure-Based Discovery of a Selective KDM5A Inhibitor that Exhibits Anti-Cancer Activity via Inducing Cell Cycle Arrest and Senescence in Breast Cancer Cell Lines","volume":"11","author":"Yang","year":"2019","journal-title":"Cancers (basel)"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107945_b0110","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10822-012-9547-0","article-title":"Docking and scoring with ICM: the benchmarking results and strategies for improvement","volume":"26","author":"Neves","year":"2012","journal-title":"J Comput Aided Mol Des"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107945_b0115","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1021\/ci500062f","article-title":"An unbiased method to build benchmarking sets for ligand-based virtual screening and its application to GPCRs","volume":"54","author":"Xia","year":"2014","journal-title":"J Chem Inf Model"},{"issue":"19","key":"10.1016\/j.bioorg.2024.107945_b0120","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.1021\/acs.jmedchem.6b00355","article-title":"Discovery and Optimization of a Selective Ligand for the Switch\/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis","volume":"59","author":"Myrianthopoulos","year":"2016","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107945_b0125","doi-asserted-by":"crossref","first-page":"e1293","DOI":"10.1038\/cddis.2014.250","article-title":"Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening","volume":"5","author":"Liu","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bioorg.2024.107945_b0130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/(SICI)1097-0134(1997)1+<215::AID-PROT29>3.0.CO;2-Q","article-title":"Flexible protein-ligand docking by global energy optimization in internal coordinates","volume":"Suppl 1","author":"Totrov","year":"1997","journal-title":"Proteins"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107945_b0135","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/s41467-017-02084-0","article-title":"The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand","volume":"8","author":"Chan","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107945_b0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10822-011-9516-z","article-title":"Computational chemistry in 25 years","volume":"26","author":"Abagyan","year":"2012","journal-title":"J Comput Aided Mol Des"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107945_b0145","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"issue":"7078","key":"10.1016\/j.bioorg.2024.107945_b0150","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nature04433","article-title":"Histone demethylation by a family of JmjC domain-containing proteins","volume":"439","author":"Tsukada","year":"2006","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107945_b0155","doi-asserted-by":"crossref","first-page":"966","DOI":"10.24272\/j.issn.2095-8137.2022.234","article-title":"Antiviral effects of natural small molecules on aquatic rhabdovirus by interfering with early viral replication","volume":"43","author":"Zhou","year":"2022","journal-title":"Zool Res"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107945_b0160","doi-asserted-by":"crossref","first-page":"e12739","DOI":"10.1111\/cpr.12739","article-title":"Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K\/AKT\/mTOR pathway","volume":"53","author":"Zhou","year":"2020","journal-title":"Cell Prolif"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107945_b0165","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/nprot.2006.236","article-title":"Quantification of mRNA using real-time RT-PCR","volume":"1","author":"Nolan","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.bioorg.2024.107945_b0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-0716-2736-5_4","article-title":"Flow Cytometry and Cell Cycle Analysis: An Overview","volume":"2579","author":"Rieger","year":"2022","journal-title":"Methods Mol Biol"},{"issue":"12","key":"10.1016\/j.bioorg.2024.107945_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111361","article-title":"Meteorin links the bone marrow hypoxic state to hematopoietic stem\/progenitor cell mobilization","volume":"40","author":"Dai","year":"2022","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107945_b0180","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1038\/s41467-024-48328-8","article-title":"TFPI from erythroblasts drives heme production in central macrophages promoting erythropoiesis in polycythemia","volume":"15","author":"Ma","year":"2024","journal-title":"Nat Commun"},{"issue":"20","key":"10.1016\/j.bioorg.2024.107945_b0185","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1039\/C7CC09384E","article-title":"Identification of a rhodium(iii) complex as a Wee1 inhibitor against TP53-mutated triple-negative breast cancer cells","volume":"54","author":"Yang","year":"2018","journal-title":"Chem Commun (camb)"},{"issue":"6141","key":"10.1016\/j.bioorg.2024.107945_b0190","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Martinez Molina","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2024.107945_b0195","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1038\/ncomms8769","article-title":"PI3K\/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis","volume":"6","author":"Lee","year":"2015","journal-title":"Nat Commun"},{"issue":"31","key":"10.1016\/j.bioorg.2024.107945_b0200","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1038\/s41388-018-0267-3","article-title":"Ubiquitylation and degradation of adenomatous polyposis coli by MKRN1 enhances Wnt\/\u03b2-catenin signaling","volume":"37","author":"Lee","year":"2018","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.bioorg.2024.107945_b0205","doi-asserted-by":"crossref","first-page":"eadj4009","DOI":"10.1126\/sciadv.adj4009","article-title":"SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1","volume":"10","author":"Deng","year":"2024","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107945_b0210","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1038\/s41598-024-56830-8","article-title":"MKRN1 regulates the expression profiles and transcription factor activity in HeLa cells inhibition suppresses cervical cancer cell progression","volume":"14","author":"Dong","year":"2024","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.bioorg.2024.107945_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13091478","article-title":"Targeting BRAF Activation as Acquired Resistance Mechanism to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small-Cell Lung Cancer","volume":"13","author":"Aboubakar Nana","year":"2021","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107945_b0220","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11655-012-1098-7","article-title":"The absorption and transport of magnolol in Caco-2 cell model","volume":"19","author":"Wu","year":"2013","journal-title":"Chin J Integr Med"},{"issue":"9","key":"10.1016\/j.bioorg.2024.107945_b0225","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat Protoc"},{"issue":"24","key":"10.1016\/j.bioorg.2024.107945_b0230","doi-asserted-by":"crossref","first-page":"13497","DOI":"10.1080\/07391102.2021.1989040","volume":"40","author":"Kumari","year":"2022","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bioorg.2024.107945_b0235","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ncomms1981","article-title":"Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis","volume":"3","author":"Lee","year":"2012","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107945_b0240","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/cai2.70","article-title":"A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer","volume":"2","author":"Zhang","year":"2023","journal-title":"Cancer Innov"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107945_b0245","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/cai2.100","article-title":"Advances in research on molecular markers in immune checkpoint inhibitor-associated myocarditis","volume":"2","author":"Shao","year":"2023","journal-title":"Cancer Innov"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107945_b0250","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/cai2.91","article-title":"Current insights into the oncogenic roles of lncRNA LINC00355","volume":"2","author":"Shen","year":"2023","journal-title":"Cancer Innov"},{"issue":"26","key":"10.1016\/j.bioorg.2024.107945_b0255","doi-asserted-by":"crossref","first-page":"39931","DOI":"10.18632\/oncotarget.9539","article-title":"Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance","volume":"7","author":"Gale","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2024.107945_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2015.01.002","article-title":"Targeting histone lysine methylation in cancer","volume":"150","author":"McGrath","year":"2015","journal-title":"Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107945_b0265","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.celrep.2014.02.004","article-title":"Histone demethylase RBP2 is critical for breast cancer progression and metastasis","volume":"6","author":"Cao","year":"2014","journal-title":"Cell Rep"},{"issue":"11","key":"10.1016\/j.bioorg.2024.107945_b0270","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107945_b0275","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1021\/acs.jmedchem.5b01527","article-title":"Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors","volume":"59","author":"Korczynska","year":"2016","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107945_b0280","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/ard-2022-223789","article-title":"Inhibition of KDM7A\/B histone demethylases restores H3K79 methylation and protects against osteoarthritis","volume":"82","author":"Assi","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107945_b0285","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13046-023-02788-w","article-title":"MKRN1 promotes colorectal cancer metastasis by activating the TGF-\u03b2 signalling pathway through SNIP1 protein degradation","volume":"42","author":"Zhang","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"issue":"18","key":"10.1016\/j.bioorg.2024.107945_b0290","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.1021\/jm400624b","article-title":"Identification of the KDM2\/7 histone lysine demethylase subfamily inhibitor and its antiproliferative activity","volume":"56","author":"Suzuki","year":"2013","journal-title":"J Med Chem"},{"issue":"26","key":"10.1016\/j.bioorg.2024.107945_b0295","doi-asserted-by":"crossref","first-page":"7136","DOI":"10.1039\/D2SC05944D","article-title":"Cyclic peptides target the aromatic cage of a PHD-finger reader domain to modulate epigenetic protein function","volume":"14","author":"Coleman","year":"2023","journal-title":"Chem Sci"},{"issue":"40","key":"10.1016\/j.bioorg.2024.107945_b0300","doi-asserted-by":"crossref","first-page":"13091","DOI":"10.1002\/anie.201807305","article-title":"Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy","volume":"57","author":"Yang","year":"2018","journal-title":"Angew Chem Int Ed Engl"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107945_b0305","article-title":"The State-of-the-Art Antibacterial Activities of Glycyrrhizin","volume":"12","author":"Chen","year":"2024","journal-title":"A Comprehensive Review. Microorganisms"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107945_b0310","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jconrel.2004.10.012","article-title":"Influence of molecular weight on oral absorption of water soluble chitosans","volume":"102","author":"Chae","year":"2005","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107945_b0315","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1517\/17460441.2012.648612","article-title":"Going further than Lipinski's rule in drug design","volume":"7","author":"Walters","year":"2012","journal-title":"Expert Opin Drug Discov"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107945_b0320","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cbpa.2006.06.014","article-title":"A practical view of 'druggability'","volume":"10","author":"Keller","year":"2006","journal-title":"Curr Opin Chem Biol"},{"issue":"8","key":"10.1016\/j.bioorg.2024.107945_b0325","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1021\/cr950066q","article-title":"Bioisosterism: A Rational Approach in Drug Design","volume":"96","author":"Patani","year":"1996","journal-title":"Chem Rev"},{"issue":"9","key":"10.1016\/j.bioorg.2024.107945_b0330","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.chembiol.2003.09.002","article-title":"The process of structure-based drug design","volume":"10","author":"Anderson","year":"2003","journal-title":"Chem Biol"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107945_b0335","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrd2220","article-title":"A decade of fragment-based drug design: strategic advances and lessons learned","volume":"6","author":"Hajduk","year":"2007","journal-title":"Nat Rev Drug Discov"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824008502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824008502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:28:55Z","timestamp":1738204135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824008502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":67,"alternative-id":["S0045206824008502"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107945","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-Based identification of a potent KDM7A inhibitor exerts anticancer activity through transcriptionally reducing MKRN1 in taxol- resistant and -sensitive triple-negative breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107945","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107945"}}